A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma

<div>Function enrichment analyses of 2183 genes involved in the levels of PCBP1-AS1: (a) GO enrichment analysis; (b) KEGG pathway enrichment analysis.</div>

Journal of Immunology Research

fig3

Figure 3

Figure 3: A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma 